Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 8439962)


Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.

Spruck CH 3rd, Rideout WM 3rd, Olumi AF, Ohneseit PF, Yang AS, Tsai YC, Nichols PW, Horn T, Hermann GG, Steven K, et al.

Cancer Res. 1993 Mar 1;53(5):1162-6. Erratum in: Cancer Res 1993 May 15;53(10 Suppl):2427.


Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.

Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):297-302. Erratum in: Cancer Epidemiol Biomarkers Prev 2001 Dec;10(12):1309.


Influence of cigarette smoking on P53 gene mutations in bladder carcinomas.

Bernardini S, Adessi GL, Chezy E, Billerey C, Carbillet JP, Bittard H.

Anticancer Res. 2001 Jul-Aug;21(4B):3001-4.


p53 and K-ras mutations in lung cancers from former and never-smoking women.

Vähäkangas KH, Bennett WP, Castrén K, Welsh JA, Khan MA, Blömeke B, Alavanja MC, Harris CC.

Cancer Res. 2001 Jun 1;61(11):4350-6.


Prevalence and spectrum of p53 mutations associated with smoking in breast cancer.

Conway K, Edmiston SN, Cui L, Drouin SS, Pang J, He M, Tse CK, Geradts J, Dressler L, Liu ET, Millikan R, Newman B.

Cancer Res. 2002 Apr 1;62(7):1987-95.


Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.

Hussain SP, Amstad P, Raja K, Sawyer M, Hofseth L, Shields PG, Hewer A, Phillips DH, Ryberg D, Haugen A, Harris CC.

Cancer Res. 2001 Sep 1;61(17):6350-5.


Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer.

Habuchi T, Takahashi R, Yamada H, Ogawa O, Kakehi Y, Ogura K, Hamazaki S, Toguchida J, Ishizaki K, Fujita J, et al.

Cancer Res. 1993 Aug 15;53(16):3795-9.


Distribution of p53 and K-ras mutations in human lung cancer tissues.

Gao HG, Chen JK, Stewart J, Song B, Rayappa C, Whong WZ, Ong T.

Carcinogenesis. 1997 Mar;18(3):473-8.


p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity.

Ostwald C, Gogacz P, Hillmann T, Schweder J, Gundlach K, Kundt G, Barten M.

Int J Cancer. 2000 Oct 1;88(1):82-6.


Cigarette smoking and p53 mutations in lung cancer and bladder cancer.

Husgafvel-Pursiainen K, Kannio A.

Environ Health Perspect. 1996 May;104 Suppl 3:553-6.


p53 mutations in human bladder cancer.

Kusser WC, Miao X, Glickman BW, Friedland JM, Rothman N, Hemstreet GP, Mellot J, Swan DC, Schulte PA, Hayes RB.

Environ Mol Mutagen. 1994;24(3):156-60.


Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.

Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.

Cancer. 1997 Feb 15;79(4):700-16.


P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers.

LaRue H, Allard P, Simoneau M, Normand C, Pfister C, Moore L, Meyer F, Têtu B, Fradet Y.

Carcinogenesis. 2000 Jan;21(1):101-6.


High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.

Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.

Cancer Res. 1998 Jan 15;58(2):328-33.


P53 alterations in bladder tumors from arsenic and tobacco exposed patients.

Moore LE, Smith AH, Eng C, DeVries S, Kalman D, Bhargava V, Chew K, Ferreccio C, Rey OA, Hopenhayn C, Biggs ML, Bates MN, Waldman FM.

Carcinogenesis. 2003 Nov;24(11):1785-91. Epub 2003 Aug 14.


Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.

Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P.

Oncogene. 2002 Oct 21;21(48):7435-51. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk